Overview
Italy has no separate legal category for 'research peptides': any peptide with a pharmacological action is treated as a medicine, so it can only be lawfully supplied through authorised, prescription-controlled channels, and unauthorised sale or personal supply falls outside the law. On top of medicines law, Italy operates a criminal anti-doping regime (Law 376/2000, now Art. 586-bis of the Criminal Code) whose official substance list expressly names growth-hormone-releasing and related peptides, with prison sentences for supplying or trafficking them outside pharmacy channels. GLP-1 medicines such as semaglutide are authorised but tightly indication-restricted, and the Ministry of Health has previously banned pharmacy compounding of weight-loss magistral preparations on AIFA's recommendation. Newer 'research' peptides such as BPC-157 and TB-500 are not authorised medicines and are not sold legally to consumers, though no Italian instrument naming them specifically was located.
Key Points
- Peptide drugs are regulated as medicines with tightly controlled indications: AIFA states that semaglutide (Ozempic) is indicated only for inadequately controlled type 2 diabetes and that any other use, including weight management, is off-label. [1]
- Italy's official doping list expressly names peptide hormones and growth factors in class S2, including somatropin, GHRH, GHRP-2 (pralmorelin), GHRP-6 and CJC-1295. [2]
- The list of substances whose use is considered doping was most recently replaced by the Ministry of Health decree of 28 May 2025, published in Gazzetta Ufficiale no. 168 of 22 July 2025, which transposes the WADA list and keeps peptide hormones and growth factors (S2) prohibited both in and out of competition. [3]
- Under Article 9 of Law 376/2000, procuring, administering, taking or facilitating the use of listed doping substances to alter athletic performance is punishable by three months to three years' imprisonment plus a fine, while trading such substances through channels other than pharmacies and other authorised dispensing structures carries two to six years' imprisonment. [4]
- Italy uses ministerial decrees to shut down pharmacy compounding of weight-loss preparations: acting on AIFA pharmacovigilance reports, the Ministry of Health prohibited doctors from prescribing and pharmacists from compounding magistral preparations for slimming purposes containing the listed active ingredients, alone or in combination. [5]
- Enforcement against the grey market is active, with Italian reporting on a large seizure tied to online trafficking of doping substances and an unauthorised slimming drug popularised on TikTok. [6]
- No Italian statute, decree or AIFA measure specifically naming BPC-157 or TB-500 was located in this research; the conclusion that they are unauthorised and cannot be lawfully sold for human use is an inference from general Italian medicines law rather than a direct peptide-specific source. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
- No Italy-specific customs or personal-import instrument dealing with research peptides was found during this research, so the practical treatment of personal imports (including postal shipments) could not be confirmed from a primary source and should be verified with the Agenzia delle Dogane and the Ministry of Health. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)